New diabetes clinical trial: A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Published on: May 31, 2019 at 07:00PM
Condition:   Non-alcoholic Steatohepatitis
Interventions:   Drug: Placebo;   Drug: PF-06835919
Sponsor:   Pfizer
Not yet recruiting